CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cassiopea SpA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cassiopea SpA
Via Cristoforo Colombo 1
LAINATE, 20020  Italy Ticker: SKINSKIN

Business Summary
Cassiopea SpA is an Italy-based company engaged in the biotechnology and medical research industry. The Company is a clinical stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products. The Company's current focus is on the topical treatment of acne, androgenic alopecia (''AGA'') and genital warts. Its portfolio comprises four clinical candidates, such as Winlevi, Breezula, CB-06-01 and CB-06-02, for which the Company owns the worldwide rights. These product candidates are based on three chemical entities (''NCE''). They target unmet medical needs and addressable opportunities in the medical dermatology market. The main shareholder of the Company is Cosmo Pharmaceuticals SA.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201912/31/2018Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman, Non-Executive Director Jande Vries 74 5/1/2015 5/1/2015
Chief Executive Officer, Executive Director DianaHarbort 51 5/1/2015 5/1/2015
Chief Financial Officer, Head of Investor Relations Hans C.Tanner 68 1/1/2015 1/1/2015
6 additional Officers and Directors records available in full report.

Business Names
Business Name
0R8Y
CSP
SKIN

General Information
Number of Employees: 12 (As of 6/30/2019)
Outstanding Shares: 10,000,000 (As of 6/30/2019)
Stock Exchange: SWF


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 16, 2019